Why Tilray And Canopy Growth Are Trading Higher Today

Why Tilray And Canopy Growth Are Trading Higher Today

Shares of cannabis companies such as Tilray, Inc. TLRY and Canopy Growth Corporation CGC are trading higher after BofA Securities reinstated a Buy rating on the stocks.

BofA Securities analyst Heather Balsky reinstated a Buy rating on Tilray's stock with a $23 price target, while Canopy Growth received a $36 price target.

Tilray cultivates and sells medical and recreational cannabis. The stock was trading up 8.7% at $19.26 at the time of publication. The stock has a 52-week high of $67 and a 52-week low of $4.41.

Canopy Growth cultivates and sells medicinal and recreational cannabis, and hemp. The stock was trading up 4% at $28. The stock has a 52-week high of $56.50 and a 52-week low of $12.95.

See also: How to Buy Tilray Here (ACB) Stock 

Posted In: why its movingCannabisPrice TargetMarketsAnalyst RatingsMoversTrading Ideas

BENZINGA CANNABIS CONFERENCE

Meet the biggest cannabis industry players and make deals that will push the industry forward.

Featuring live company presentations, insider panels, and unmatched access to networking, the Benzinga Cannabis Capital Conference is where cannabis executives and entrepreneurs meet.

Join us April 11-12, 2023 at Fontainebleau Miami Beach in sunny Florida.